Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

Elbadawi, Ayman; Sedhom, Ramy; Gad, Mohamed M.; Hamed, Mohamed; Elwagdy, Amr; Barakat, Amr F.; Khalid, Umair; Mamas, Mamas A.; Birnbaum, Yochai; Elgendy, Islam Y.; Jneid, Hani

doi:10.1016/j.ejim.2022.07.015

Cited by 14 publications

(10 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A meta-analysis of 9 RCTs (N=85 209) examining systematic screening, opportunistic screening, and no screening determined that any AF screening (systematic or opportunistic) was associated with higher detection of AF (1.8% versus 1.3%; RR, 2.10 [95% CI, 1.20–3.65]) than no screening. 139…”

Section: Disorders Of Heart Rhythmmentioning

confidence: 99%

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin,

Aday,

Almarzooq

et al. 2024

Circulation

174

View full text Add to dashboard Cite

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). METHODS: The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional global data, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. RESULTS: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

show abstract

Section: Disorders Of Heart Rhythmmentioning

confidence: 99%

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin,

Aday,

Almarzooq

et al. 2024

Circulation

174

View full text Add to dashboard Cite

show abstract

“…In another meta-analysis of 9 studies and overall 85,209 patients, which differed by one study from the previous meta-analysis (mSTOPS instead of HECTOR-AF), any AF screening (either systematic or opportunistic) was associated with higher initiation of oral anticoagulation (RR 3.26; 95% CI 1.15–9.23), compared with no screening. 43 There was no significant difference between any AF screening vs no screening in all-cause mortality (RR 0.97; 95% CI 0.93–1.01) or acute cerebrovascular accident (RR 0.92; 95% CI 0.84–1.01). Only systematic screening was associated with higher initiation of oral anticoagulation (RR 5.67; 95% CI 2.68–11.99), compared with no screening.…”

Section: Different Approaches For Atrial Fibrillation Screeningmentioning

confidence: 84%

Atrial fibrillation: epidemiology, screening and digital health

Linz,

Gawalko,

Betz

et al. 2024

The Lancet Regional Health - Europe

View full text Add to dashboard Cite

“…Opportunistic screening using the single-lead ECG or combined with pulse palpation and blood pressure measurement in individuals aged ≥ 65 years did not significantly increase the detection rate of AF. [34][35][36] Systematic screening in individuals aged ≥ 70 years without AF can significantly increase the detection rate of AF, but the benefits of anticoagulation therapy based on screening results remain controversial. [37][38][39] Based on current evidence, the Guidelines recommend considering opportunistic screening for AF through pulse palpation or ECG during medical visits for individuals aged ≥ 65 years and considering systematic screening for AF through regular or continuous electrocardiographic monitoring for individuals aged ≥ 70 years.…”

Section: Af Screening In the General Populationmentioning

confidence: 99%

“…Opportunistic screening for AF can be considered in individuals aged ≥ 65 years during medical visits, using methods such as pulse palpation or electrocardiography. [34][35][36] Ⅱb A Systematic screening for AF through regular or continuous electrocardiographic monitoring may be considered in the population aged ≥ 70 years. [37][38][39] Ⅱb A…”

Section: General Populationmentioning

confidence: 99%

Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation

MA,

WU,

LIU

et al. 2024

Journal of Geriatric Cardiology

View full text Add to dashboard Cite

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, significantly impacting patients' quality of life and increasing the risk of death, stroke, heart failure, and dementia. Over the past two decades, there have been significant breakthroughs in AF risk prediction and screening, stroke prevention, rhythm control, catheter ablation, and integrated management. During this period, the scale, quality, and experience of AF management in China have greatly improved, providing a solid foundation for the development of guidelines for the diagnosis and management of AF. To further promote standardized AF management, and apply new technologies and concepts to clinical practice in a timely and comprehensive manner, the Chinese Society of Cardiology of the Chinese Medical Association and the Heart Rhythm Committee of the Chinese Society of Biomedical Engineering have jointly developed the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation. The guidelines have comprehensively elaborated on various aspects of AF management and proposed the CHA 2 DS 2 -VASc-60 stroke risk score based on the characteristics of AF in the Asian population. The guidelines have also reevaluated the clinical application of AF screening, emphasized the significance of early rhythm control, and highlighted the central role of catheter ablation in rhythm control.

show abstract

Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

Cited by 14 publications

References 35 publications

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Atrial fibrillation: epidemiology, screening and digital health

Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation

Contact Info

Product

Resources

About